Log In
BCIQ
Print this Print this
 

Somavaratan (VRS-317)

Also known as: human growth hormone (hGH)-XTEN

  Manage Alerts
Collapse Summary General Information
Company Amunix Operating Inc.
DescriptionLong-acting recombinant human growth hormone (rhGH)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD); Treat growth hormone deficiency (GHD) in adults; Treat growth hormone deficiency (GHD) in children
Regulatory Designation U.S. - Orphan Drug (Treat growth hormone deficiency (GHD));
EU - Orphan Drug (Treat growth hormone deficiency (GHD))
PartnerTeijin Pharma Ltd.;
Versartis Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$165.0M

$40.0M

$125.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2016

$165.0M

$40.0M

$125.0M

Get a free BioCentury trial today